BioWorld - Friday, July 17, 2026

Artificial intelligence
Artificial intelligence RSS Feed RSS

Illustration of digital syringe
Immune

Evaxion partners to advance new bacterial vaccine program

Sep. 19, 2023
Evaxion Biotech A/S has announced the initiation of a novel pipeline program, EVX-B3, an artificial intelligence (AI)-designed vaccine candidate against an undisclosed bacterial pathogen. The new vaccine project will be the subject of a co-funded collaboration between Evaxion and an undisclosed partner.
Read More
Hand holding gear, dollar sign

Pitango Healthtech raises $175M for new fund

Sep. 6, 2023
By Shani Alexander

Israel’s venture capital firm Pitango has raised $175 million for a new fund focused on backing entrepreneurs leveraging data science, artificial intelligence (AI), medical devices and novel biology to transform health care. Pitango Healthtech II is the firm’s second fund dedicated to health care and will see investment go into 15 companies ranging from those at the seed stage to those wanting commercial stage investment.


Read More

UK allocates £13M for research into AI projects in health care

Aug. 31, 2023
By Shani Alexander
The U.K. government’s recent allocation of £13 million (US$16.5 million) to fund research that will deliver cutting-edge artificial intelligence (AI) projects is a sign of its ongoing commitment to use the latest innovative technologies to modernize the health care sector. However, a group of MPs have released a report which warned that although AI offers significant opportunities there remains governance challenges that must be addressed.
Read More
Hands holding gears
Drug Design, Drug Delivery & Technologies

Serengen and Deargen establish drug discovery collaboration

Aug. 30, 2023
Serengen GmbH and Deargen Inc. have established a collaboration to accelerate the drug discovery process by bringing together Serengen’s novel DNA encoded library (DEL) technology with Deargen’s artificial intelligence (AI)-driven drug discovery platform, Deardti.
Read More